Monkey models of tuberculosis: Lessons learned

Infection and Immunity

Volumn 83, Issue 3, 2015, Pages 852-862

  Peñ, Juliet C ^b,c   Ho, Wen Zhe ^a,b  

^a WUHAN UNIVERSITY   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE COURSE; DRUG EFFICACY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA FASCICULARIS; MIXED INFECTION; MONKEY MODEL; MYCOBACTERIUM TUBERCULOSIS TEST KIT; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHESUS MONKEY; SHORT SURVEY; TUBERCULIN TEST; TUBERCULOSIS; ANIMAL; DISEASE MODEL; HISTORY; IMMUNOLOGY; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PATHOPHYSIOLOGY; SPECIES DIFFERENCE; TUBERCULOSIS, PULMONARY; VETERINARY; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LATENT TUBERCULOSIS; MACACA FASCICULARIS; MACACA MULATTA; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY;

EID: 84922962816     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02850-14     Document Type: Short Survey

References (69)

1. World Health Organization. 2013. Global tuberculosis report 2013. World Health Organization, Geneva, Switzerland.
2. Basaraba RJ. 2008. Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. Tuberculosis 88(Suppl 1):S35-S47. http://dx.doi.org/10.1016/S1472-9792(08)70035-0.
3. Dharmadhikari AS, Nardell EA. 2008. What animal models teach humans about tuberculosis. Am J Respir Cell Mol Biol 39:503-508. http://dx.doi.org/10.1165/rcmb.2008-0154TR.
4. Scanga CA, Flynn JL. 2014. Modeling tuberculosis in nonhuman primates. Cold Spring Harbor Perspect Med 4:a018564. http://dx.doi.org/10.1101/cshperspect.a018564.
5. Kaushal D, Mehra S, Didier PJ, Lackner AA. 2012. The non-human primate model of tuberculosis. J Med Primatol 41:191-201. http://dx.doi.org/10.1111/j.1600-0684.2012.00536.x.
6. Flynn JL. 2006. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 8:1179-1188. http://dx.doi.org/10.1016/j.micinf.2005.10.033.
7. Ackermann RR, Baliff J, Foxman S, Helbig J, Lesser J, Mosbacher M, Senturia S, Sklar D, Sothman P. 2003. Long-tailed or crab-eating macaque and rhesus macaque, p 18-24. In Ackermann RR (ed), A comparative primate anatomy: dissection manual. Washington University in St. Louis, St. Louis, MO. http://web.uct.ac.za/depts/age/people/dissect.pdf.
8. Carlsson HE, Schapiro SJ, Farah I, Hau J. 2004. Use of primates in research: a global overview. Am J Primatol 63:225-237. http://dx.doi.org/10.1002/ajp.20054.
9. O'Neil RM, Ashack RJ, Goodman FR. 1981. A comparative study of the respiratory responses to bronchoactive agents in rhesus and cynomolgus monkeys. J Pharmacol Methods 5:267-273. http://dx.doi.org/10.1016/0160-5402(81)90094-2.
10. Capuano SV, III, Croix DA, Pawar S, Zinovik A, Myers A, Lin PL, Bissel S, Fuhrman C, Klein E, Flynn JL. 2003. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 71:5831-5844. http://dx.doi.org/10.1128/IAI.71.10.5831-5844.2003.
11. Wolf RH, Gibson SV, Watson EA, Baskin GB. 1988. Multidrug chemotherapy of tuberculosis in rhesus-monkeys. Lab Anim Sci 38:25-33.
12. Schmidt L. 1966. Studies on the antituberculous activity of ethambutol in monkeys. Ann N Y Acad Sci 135:747-758. http://dx.doi.org/10.1111/j.1749-6632.1966.tb45520.x.
13. Darrah PA, Bolton DL, Lackner AA, Kaushal D, Aye PP, Mehra S, Blanchard JL, Didier PJ, Roy CJ, Rao SS, Hokey DA, Scanga CA, Sizemore DR, Sadoff JC, Roederer M, Seder RA. 2014. Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge. J Immunol 193:1799-1811. http://dx.doi.org/10.4049/jimmunol.1400676.
14. Mehra S, Alvarez X, Didier PJ, Doyle LA, Blanchard JL, Lackner AA, Kaushal D. 2013. Granuloma correlates of protection against TB and mechanisms of immune modulation by Mycobacterium tuberculosis. J Infect Dis 207:1115-1127. http://dx.doi.org/10.1093/infdis/jis778.
15. Larsen MH, Biermann K, Chen B, Hsu T, Sambandamurthy VK, Lackner AA, Aye PP, Didier P, Huang D, Shao L, Wei H, Letvin NL, Frothingham R, Haynes BF, Chen ZW, Jacobs WR, Jr. 2009. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. Vaccine 27: 4709-4717. http://dx.doi.org/10.1016/j.vaccine.2009.05.050.
16. McMurray DN. 2000. A nonhuman primate model for preclinical testing of new tuberculosis vaccines. Clin Infect Dis 30(Suppl 3):S210-S212. http://dx.doi.org/10.1086/313885.
17. Good RC. 1968. Biology of the mycobacterioses. Simian tuberculosis: immunologic aspects. Ann N Y Acad Sci 154:200-213.
18. Barclay WR, Anacker RL, Brehmer W, Leif W, Ribi E. 1970. Aerosolinduced tuberculosis in subhuman primates and the course of the disease after intravenous BCG vaccination. Infect Immun 2:574-582.
19. Baram P, Soltysik L, Condoulis W. 1971. The in vitro assay of tuberculin hypersensitivity in Macaca mulatta sensitized with bacille Calmette Guerin cell wall vaccine and/or infected with virulent Mycobacterium tuberculosis. Lab Anim Sci 21:727-733.
20. Ribi E, Anacker R, Barclay W, Brehmer W, Harris S, Leif W, Simmons J. 1971. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the rhesus monkey. J Infect Dis 123:527-538. http://dx.doi.org/10.1093/infdis/123.5.527.
21. Barclay WR, Busey WM, Dalgard DW, Good RC, Janicki BW, Kasik JE, Ribi E, Ulrich CE, Wolinsky E. 1973. Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am Rev Respir Dis 107:351-358.
22. Janicki B, Good R, Minden P, Affronti L, Hymes W. 1973. Immune responses in rhesus monkeys after bacillus Calmette-Guerin vaccination and aerosol challenge with Mycobacterium tuberculosis. Am Rev Respir Dis 107:359.
23. Chaparas S, Good R, Janicki B. 1975. Tuberculin-induced lymphocyte transformation and skin reactivity in monkeys vaccinated or not vaccinated with Bacille Calmette-Guerin, then challenged with virulent Mycobacterium tuberculosis. Am Rev Respir Dis 112:43-47.
24. Harper GJ, Morton JD. 1953. The respiratory retention of bacterial aerosols: experiments with radioactive spores. J Hygiene 51:372-385. http://dx.doi.org/10.1017/S0022172400015801.
25. Walsh GP, Tan EV, de la Cruz EC, Abalos RM, Villahermosa LG, Young LJ, Cellona RV, Nazareno JB, Horwitz MA. 1996. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med 2:430-436. http://dx.doi.org/10.1038/nm0496-430.
26. Gormus BJ, Blanchard JL, Alvarez XH, Didier PJ. 2004. Evidence for a rhesus monkey model of asymptomatic tuberculosis. J Med Primatol 33: 134-145. http://dx.doi.org/10.1111/j.1600-0684.2004.00062.x.
27. Lewinsohn DM, Tydeman IS, Frieder M, Grotzke JE, Lines RA, Ahmed S, Prongay KD, Primack SL, Colgin LM, Lewis AD, Lewinsohn DA. 2006. High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque. Microbes Infect 8:2587-2598. http://dx.doi.org/10.1016/j.micinf.2006.07.007.
28. Magalhaes I, Sizemore DR, Ahmed RK, Mueller S, Wehlin L, Scanga C, Weichold F, Schirru G, Pau MG, Goudsmit J, Kuhlmann-Berenzon S, Spangberg M, Andersson J, Gaines H, Thorstensson R, Skeiky YA, Sadoff J, Maeurer M. 2008. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PLoS One 3:e3790. http://dx.doi.org/10.1371/journal.pone.0003790.
29. Rahman S, Magalhaes I, Rahman J, Ahmed RK, Sizemore DR, Scanga CA, Weichold F, Verreck F, Kondova I, Sadoff J, Thorstensson R, Spangberg M, Svensson M, Andersson J, Maeurer M, Brighenti S. 2012. Prime-boost vaccination with rBCG/rAd35 enhances CD8(+) cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates. Mol Med 18:647-658. http://dx.doi.org/10.2119/molmed.2011.00222.
30. Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, Braskamp G, van der Werff NM, Kersbergen A, Ottenhoff TH, Heidt PJ, Gilbert SC, Gicquel B, Hill AV, Martin C, McShane H, Thomas AW. 2009. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS One 4:e5264. http://dx.doi.org/10.1371/journal.pone.0005264.
31. Sharpe SA, McShane H, Dennis MJ, Basaraba RJ, Gleeson F, Hall G, McIntyre A, Gooch K, Clark S, Beveridge NE, Nuth E, White A, Marriott A, Dowall S, Hill AV, Williams A, Marsh PD. 2010. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing. Clin Vaccine Immunol 17:1170-1182. http://dx.doi.org/10.1128/CVI.00079-10.
32. Mehra S, Pahar B, Dutta NK, Conerly CN, Philippi-Falkenstein K, Alvarez X, Kaushal D. 2010. Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS One 5:e12266. http://dx.doi.org/10.1371/journal.pone.0012266.
33. Dutta NK, Mehra S, Didier PJ, Roy CJ, Doyle LA, Alvarez X, Ratterree M, Be NA, Lamichhane G, Jain SK, Lacey MR, Lackner AA, Kaushal D. 2010. Genetic requirements for the survival of tubercle bacilli in primates. J Infect Dis 201:1743-1752. http://dx.doi.org/10.1086/652497.
34. Zhang J, Ye YQ, Wang Y, Mo PZ, Xian QY, Rao Y, Bao R, Dai M, Liu JY, Guo M, Wang X, Huang ZX, Sun LH, Tang ZJ, Ho WZ. 2011. M. tuberculosis H37Rv infection of Chinese rhesus macaques. J Neuroimmune Pharmacol 6:362-370. http://dx.doi.org/10.1007/s11481-010-9245-4.
35. Zhang J, Xian Q, Guo M, Huang Z, Rao Y, Wang Y, Wang X, Bao R, Evans TG, Hokey D, Sizemore D, Ho WZ. 2014. Mycobacterium tuberculosis Erdman infection of rhesus macaques of Chinese origin. Tuberculosis 94:634-643. http://dx.doi.org/10.1016/j.tube.2014.08.005.
36. Mehra S, Golden NA, Dutta NK, Midkiff CC, Alvarez X, Doyle LA, Asher M, Russell-Lodrigue K, Monjure C, Roy CJ, Blanchard JL, Didier PJ, Veazey RS, Lackner AA, Kaushal D. 2011. Reactivation of latent tuberculosis in rhesus macaques by coinfection with simian immunodeficiency virus. J Med Primatol 40:233-243. http://dx.doi.org/10.1111/j.1600-0684.2011.00485.x.
37. Luciw PA, Oslund KL, Yang XW, Adamson L, Ravindran R, Canfield DR, Tarara R, Hirst L, Christensen M, Lerche NW, Offenstein H, Lewinsohn D, Ventimiglia F, Brignolo L, Wisner ER, Hyde DM. 2011. Stereological analysis of bacterial load and lung lesions in nonhuman primates (rhesus macaques) experimentally infected with Mycobacterium tuberculosis. Am J Physiol Lung Cell Mol Physiol 301:L731-L738. http://dx.doi.org/10.1152/ajplung.00120.2011.
38. Dutta NK, Mehra S, Martinez AN, Alvarez X, Renner NA, Morici LA, Pahar B, Maclean AG, Lackner AA, Kaushal D. 2012. The stressresponse factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes. PLoS One 7:e28958. http://dx.doi.org/10.1371/journal.pone.0028958.
39. Mehra S, Golden NA, Stuckey K, Didier PJ, Doyle LA, Russell-Lodrigue KE, Sugimoto C, Hasegawa A, Sivasubramani SK, Roy CJ, Alvarez X, Kuroda MJ, Blanchard JL, Lackner AA, Kaushal D. 2012. The Mycobacterium tuberculosis stress response factor SigH is required for bacterial burden as well as immunopathology in primate lungs. J Infect Dis 205: 1203-1213. http://dx.doi.org/10.1093/infdis/jis102.
40. Cepeda M, Salas M, Folwarczny J, Leandro AC, Hodara VL, de la Garza MA, Dick EJ, Jr, Owston M, Armitige LY, Gauduin MC. 2013. Establishment of a neonatal rhesus macaque model to study Mycobacterium tuberculosis infection. Tuberculosis 93(Suppl):S51-S59. http://dx.doi.org/10.1016/S1472-9792(13)70011-8.
41. Luo Q, Mehra S, Golden NA, Kaushal D, Lacey MR. 2014. Identification of biomarkers for tuberculosis susceptibility via integrated analysis of gene expression and longitudinal clinical data. Front Genet 5:240.
42. Langermans JA, Andersen P, van Soolingen D, Vervenne RA, Frost PA, van der Laan T, van Pinxteren LA, van den Hombergh J, Kroon S, Peekel I, Florquin S, Thomas AW. 2001. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci USA 98:11497-11502. http://dx.doi.org/10.1073/pnas.201404898.
43. Ravindran R, Krishnan VV, Dhawan R, Wunderlich ML, Lerche NW, Flynn JL, Luciw PA, Khan IH. 2014. Plasma antibody profiles in nonhuman primate tuberculosis. J Med Primatol 43:59-71. http://dx.doi.org/10.1111/jmp.12097.
44. Kita Y, Tanaka T, Yoshida S, Ohara N, Kaneda Y, Kuwayama S, Muraki Y, Kanamaru N, Hashimoto S, Takai H, Okada C, Fukunaga Y, Sakaguchi Y, Furukawa I, Yamada K, Inoue Y, Takemoto Y, Naito M, Yamada T, Matsumoto M, McMurray DN, Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Skeiky Y, Reed S, Sakatani M, Okada M. 2005. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. Vaccine 23:2132-2135. http://dx.doi.org/10.1016/j.vaccine.2005.01.057.
45. Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Fukamizu R, Tsunai Y, Inoue R, Nakatani H, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Sakatani M. 2007. Evaluation of a novel vaccine (HVJliposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB. Vaccine 25:2990-2993. http://dx.doi.org/10.1016/j.vaccine.2007.01.014.
46. Reed SG, Coler RN, Dalemans W, Tan EV, DeLa Cruz EC, Basaraba RJ, Orme IM, Skeiky YA, Alderson MR, Cowgill KD, Prieels JP, Abalos RM, Dubois MC, Cohen J, Mettens P, Lobet Y. 2009. Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci USA 106:2301-2306. http://dx.doi.org/10.1073/pnas.0712077106.
47. Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, Bigbee C, Chiosea I, Capuano SV, Fuhrman C, Klein E, Flynn JL. 2009. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun 77:4631-4642. http://dx.doi.org/10.1128/IAI.00592-09.
48. Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C, Grieser H, Chiosea I, Voitenek NN, Capuano SV, Klein E, Flynn JL. 2010. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum 62:340-350. http://dx.doi.org/10.1002/art.27271.
49. Green AM, Mattila JT, Bigbee CL, Bongers KS, Lin PL, Flynn JL. 2010. CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. J Infect Dis 202:533-541. http://dx.doi.org/10.1086/654896.
50. Diedrich CR, Mattila JT, Klein E, Janssen C, Phuah J, Sturgeon TJ, Montelaro RC, Lin PL, Flynn JL. 2010. Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load. PLoS One 5:e9611. http://dx.doi.org/10.1371/journal.pone.0009611.
51. Mattila JT, Diedrich CR, Lin PL, Phuah J, Flynn JL. 2011. Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation. J Immunol 186:3527-3537. http://dx.doi.org/10.4049/jimmunol.1003773.
52. Lin PL, Dietrich J, Tan E, Abalos RM, Burgos J, Bigbee C, Bigbee M, Milk L, Gideon HP, Rodgers M, Cochran C, Guinn KM, Sherman DR, Klein E, Janssen C, Flynn JL, Andersen P. 2012. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J Clin Invest 122:303-314. http://dx.doi.org/10.1172/JCI46252.
53. Phuah JY, Mattila JT, Lin PL, Flynn JL. 2012. Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis. Am J Pathol 181:508-514. http://dx.doi.org/10.1016/j.ajpath.2012.05.009.
54. Ragheb MN, Ford CB, Chase MR, Lin PL, Flynn JL, Fortune SM. 2013. The mutation rate of mycobacterial repetitive unit loci in strains of M. tuberculosis from cynomolgus macaque infection. BMC Genomics 14: 145. http://dx.doi.org/10.1186/1471-2164-14-145.
55. Chen CY, Yao SY, Huang D, Wei HY, Sicard H, Zeng GC, Jomaa H, Larsen MH, Jacobs WR, Wang R, Letvin N, Shen Y, Qiu LY, Shen L, Chen ZW. 2013. Phosphoantigen/IL2 expansion and differentiation of Vγ2Vδ2 T cells increase resistance to tuberculosis in nonhuman primates. PLoS Pathog 9:e1003501. http://dx.doi.org/10.1371/journal.ppat.1003501.
56. Lin PL, Coleman T, Carney JP, Lopresti BJ, Tomko J, Fillmore D, Dartois V, Scanga C, Frye LJ, Janssen C, Klein E, Barry CE, III, Flynn JL. 2013. Radiologic responses in cynomolgus macaques for assessing tuberculosis chemotherapy regimens. Antimicrob Agents Chemother 57: 4237-4244. http://dx.doi.org/10.1128/AAC.00277-13.
57. Lin PL, Ford CB, Coleman MT, Myers AJ, Gawande R, Ioerger T, Sacchettini J, Fortune SM, Flynn JL. 2014. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med 20:75-79. http://dx.doi.org/10.1038/nm.3412.
58. Roodgar M, Lackner A, Kaushal D, Sankaran S, Dandekar S, Satkoski Trask J, Drake C, Smith DG. 2013. Expression levels of 10 candidate genes in lung tissue of vaccinated and TB-infected cynomolgus macaques. J Med Primatol 42:161-164. http://dx.doi.org/10.1111/jmp.12040.
59. Dutta NK, McLachlan J, Mehra S, Kaushal D. 2014. Humoral and lung immune responses to Mycobacterium tuberculosis infection in a primate model of protection. Trials Vaccinol 3:47-51. http://dx.doi.org/10.1016/j.trivac.2014.02.001.
60. Sharpe SA, Eschelbach E, Basaraba RJ, Gleeson F, Hall GA, McIntyre A, Williams A, Kraft SL, Clark S, Gooch K, Hatch G, Orme IM, Marsh PD, Dennis MJ. 2009. Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis. Tuberculosis 89:405-416. http://dx.doi.org/10.1016/j.tube.2009.09.002.
61. Vervenne RA, Jones SL, van Soolingen D, van der Laan T, Andersen P, Heidt PJ, Thomas AW, Langermans JA. 2004. TB diagnosis in nonhuman primates: comparison of two interferon-gamma assays and the skin test for identification of Mycobacterium tuberculosis infection. Vet Immunol Immunopathol 100:61-71. http://dx.doi.org/10.1016/j.vetimm.2004.03.003.
62. Kanaujia GV, Motzel S, Garcia MA, Andersen P, Gennaro ML. 2004. Recognition of ESAT-6 sequences by antibodies in sera of tuberculous nonhuman primates. Clin Diagn Lab Immunol 11:222-226. http://dx.doi.org/10.1128/CDLI.11.1.222-226.2004.
63. Lyashchenko KP, Greenwald R, Esfandiari J, Greenwald D, Nacy CA, Gibson S, Didier PJ, Washington M, Szczerba P, Motzel S, Handt L, Pollock JM, McNair J, Andersen P, Langermans JA, Verreck F, Ervin S, Ervin F, McCombs C. 2007. PrimaTB STAT-PAK assay, a novel, rapid lateral-flow test for tuberculosis in nonhuman primates. Clin Vaccine Immunol 14:1158-1164. http://dx.doi.org/10.1128/CVI.00230-07.
64. Khan IH, Ravindran R, Yee J, Ziman M, Lewinsohn DM, Gennaro ML, Flynn JL, Goulding CW, DeRiemer K, Lerche NW, Luciw PA. 2008. Profiling antibodies to Mycobacterium tuberculosis by multiplex microbead suspension arrays for serodiagnosis of tuberculosis. Clin Vaccine Immunol 15:433-438. http://dx.doi.org/10.1128/CVI.00354-07.
65. Huang D, Qiu L, Wang R, Lai X, Du G, Seghal P, Shen Y, Shao L, Halliday L, Fortman J, Shen L, Letvin NL, Chen ZW. 2007. Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity. J Infect Dis 195:55-69. http://dx.doi.org/10.1086/509895.
66. Shen Y, Shen L, Sehgal P, Zhou D, Simon M, Miller M, Enimi EA, Henckler B, Chalifoux L, Sehgal N, Gastron M, Letvin NL, Chen ZW. 2001. Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG. J Virol 75:8690-8696. http://dx.doi.org/10.1128/JVI.75.18.8690-8696.2001.
67. Shen Y, Zhou DJ, Chalifoux L, Shen L, Simon M, Zeng XJ, Lai XM, Li YY, Sehgal P, Letvin NL, Chen ZW. 2002. Induction of an AIDS virusrelated tuberculosis-like disease in macaques: a model of simian immunodeficiency virus-mycobacterium coinfection. Infect Immun 70:869-877. http://dx.doi.org/10.1128/IAI.70.2.869-877.2002.
68. Via LE, Weiner DM, Schimel D, Lin PL, Dayao E, Tankersley SL, Cai Y, Coleman MT, Tomko J, Paripati P, Orandle M, Kastenmayer RJ, Tartakovsky M, Rosenthal A, Portevin D, Eum SY, Lahouar S, Gagneux S, Young DB, Flynn JL, Barry CE, III. 2013. Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus). Infect Immun 81: 2909-2919. http://dx.doi.org/10.1128/IAI.00632-13.
69. Lerche NW, Yee JL, Capuano SV, Flynn JL. 2008. New approaches to tuberculosis surveillance in nonhuman primates. ILAR J 49:170-178. http://dx.doi.org/10.1093/ilar.49.2.170.